CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more


Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

Nobel Prize awarded to scientists who discovered ‘genetic scissors’

The gene editing technology CRISPR has potential in the treatment of inherited eye conditions

genetic scissors
Scientists Emmanuelle Charpentier and Jennifer A Doudna have received the Nobel Prize in Chemistry for the development of the gene editing technology CRISPR.

The pair received 10 million Swedish kronor (877,965 GBP) in recognition of their achievement.

Professor Charpentier, who is currently based in Berlin, discovered a previously unknown molecule that is part of the ‘ancient immune system’ of bacteria, disarming viruses by cleaving their DNA.

After publishing this insight, Professor Charpentier collaborated with US-based scientist Professor Doudna to recreate the bacteria’s genetic scissors within a test tube before reprogramming the scissors so that they can cut any DNA molecule at a predetermined site.

Claes Gustafsson, chair of the Nobel Committee for Chemistry, highlighted: “There is enormous power in this genetic tool, which affects us all. It has not only revolutionised basic science, but also resulted in innovative crops and will lead to ground-breaking new medical treatments.”

CRISPR gene editing technology has potential for the treatment of inherited eye conditions.